DexCom (NASDAQ:DXCM) Price Target Raised to $151.00 at Raymo

DexCom (NASDAQ:DXCM – Get Free Report) had its price objective upped by equities researchers at Raymond James from $147.00 to $151.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ price objective indicates a potential upside […]

Related Keywords

Chicago , Illinois , United States , Stifel Nicolaus , Raymond James , Barryj Regan , Leerink Partnrs , Raymond Jame , Piper Sandler , Prudential Asset Management Co Ltd , Jpmorgan Chase Co , Chicago Capital , Quent Capital , Patriot Financial Group Insurance Agency , Fifth Third Bancorp , Dexcom Inc , Third Bancorp , Get Free Report , Asset Management Co Ltd , Financial Group Insurance Agency , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Boost Price Target ,